Development Level

Tchem 2 | 1,890
Tbio 1 | 10,625

IMPC Term

preweaning lethality, complete... 1 | 633

Disease

Alzheimer's disease 2 | 644
Brain disease 2 | 83
Cancer 2 | 2,346
Carcinoma 2 | 2,147
Heart disease 2 | 279
Liver disease 2 | 219
Mammary Neoplasms 2 | 410
diabetes mellitus 2 | 1,663
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
ovarian cancer 2 | 8,484
AORTIC VALVE DISEASE 1 1 | 2
Acrocallosal syndrome 1 | 12
Acute Promyelocytic Leukemia 1 | 31
Adams Oliver syndrome 1 | 6
Adams-Oliver syndrome 1 | 13
Adenoid Cystic Carcinoma 1 | 99
Adenoma 1 | 165
Adenomatous Polyposis Coli 1 | 10
Amphetamine-Related Disorders 1 | 74
Anemia of prematurity 1 | 1
Aortic valve calcification 1 | 3
Aortic valve disorder 1 | 1
Arthritis 1 | 248
Arthropathy 1 | 34
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 1 | 7
Breast adenocarcinoma 1 | 8
Calcinosis 1 | 62
Carcinoma, Pancreatic Ductal 1 | 19
Cardiomegaly 1 | 66
Cardiomyopathies 1 | 90
Cerebrovascular disease 1 | 231
Colon Carcinoma 1 | 25
Colonic Neoplasms 1 | 126
Colorectal Neoplasms 1 | 217
Congenital Abnormality 1 | 11
Congenital Heart Defects 1 | 37
Cowden disease 1 | 16
Craniofacial Abnormalities 1 | 147
Diabetic Retinopathy 1 | 53
Epilepsy 1 | 346
Fatty liver disease 1 | 84
Fibrosis 1 | 40
Hajdu-Cheney syndrome 1 | 8
Hamartoma Syndrome, Multiple 1 | 9
Head and neck squamous cell carcinoma 1 | 12
Heart valve disease 1 | 24
Hyperglycemia 1 | 120
Hyperinsulinism 1 | 63
Hyperplasia 1 | 26
Hypertension 1 | 287
Immune system cancer 1 | 38
Inflammation 1 | 109
Inflammatory bowel disease 1 | 142
Kidney disease 1 | 396
Leukemia, T-Cell 1 | 5
Lung Neoplasms 1 | 171
Lung disease 1 | 132
Lymphoid leukemia 1 | 69
Lymphoma 1 | 56
Malignant neoplasm of breast 1 | 63
Marijuana Abuse 1 | 8
Meningioma 1 | 26
Metabolic syndrome X 1 | 155
Muscular atrophy 1 | 67
Myopathy 1 | 128
Neoplastic Cell Transformation 1 | 81
Nerve compression syndrome 1 | 2
Neurofibromatosis 1 | 37
Neuropathy 1 | 210
Osteoarthritis 1 | 96
Osteochondritis dissecans 1 | 12
Osteoporosis 1 | 257
Otosclerosis 1 | 13
Pain 1 | 70
Parkinson's disease 1 | 364
Placental abruption 1 | 15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 | 18
Prostatic Neoplasms 1 | 471
Proteus syndrome 1 | 6
Psychoses, Substance-Induced 1 | 17
Ptosis 1 | 42
Radiculopathy 1 | 15
Retinal Degeneration 1 | 49
Scoliosis, unspecified 1 | 2
Sensorineural hearing loss 1 | 107
Skin Neoplasms 1 | 49
Skin cancer 1 | 37
Skin disease 1 | 65
Splenomegaly 1 | 7
Spondylocostal dysostosis 1 | 11
Squamous cell carcinoma 1 | 94
Squamous cell carcinoma of esophagus 1 | 82
Toxic encephalopathy 1 | 131
Uterine Cervical Neoplasm 1 | 21
Vascular disease 1 | 281
astrocytoma 1 | 1,493
nervous system disorder 1 | 53
ovarian neoplasm 1 | 97
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Non-IDG 2 | 11,971
Kinase 1 | 634

Grant Application

5R01EY006769-25 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Hypoxia-inducible factor 1-alpha inhibitor HIF1AN Tbio Non-IDG -1.87551 72.0 389
Neurogenic locus notch homolog protein 1 NOTCH1 Tchem Non-IDG -4.03035 11093.3 724
RAC-alpha serine/threonine-protein kinase AKT1 Tchem Kinase -4.29533 18275.3 3137